Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

USA - NASDAQ:XMTR - US98423F1093 - Common Stock

52.75 USD
+1.23 (+2.39%)
Last: 10/6/2025, 9:11:56 PM
52.75 USD
0 (0%)
After Hours: 10/6/2025, 9:11:56 PM
Fundamental Rating

4

Taking everything into account, XMTR scores 4 out of 10 in our fundamental rating. XMTR was compared to 49 industry peers in the Trading Companies & Distributors industry. While XMTR seems to be doing ok healthwise, there are quite some concerns on its profitability. XMTR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XMTR had positive earnings in the past year.
XMTR had a positive operating cash flow in the past year.
XMTR had negative earnings in each of the past 5 years.
In the past 5 years XMTR always reported negative operating cash flow.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

XMTR has a worse Return On Assets (-8.97%) than 87.76% of its industry peers.
XMTR has a worse Return On Equity (-22.78%) than 83.67% of its industry peers.
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 39.15%, XMTR is doing good in the industry, outperforming 69.39% of the companies in the same industry.
XMTR's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for XMTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XMTR has been increased compared to 1 year ago.
XMTR has more shares outstanding than it did 5 years ago.
XMTR has a worse debt/assets ratio than last year.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.01 indicates that XMTR is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.01, XMTR is doing good in the industry, outperforming 73.47% of the companies in the same industry.
A Debt/Equity ratio of 1.21 is on the high side and indicates that XMTR has dependencies on debt financing.
XMTR has a worse Debt to Equity ratio (1.21) than 69.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 4.01
ROIC/WACCN/A
WACC9.09%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

XMTR has a Current Ratio of 3.91. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
XMTR's Current ratio of 3.91 is amongst the best of the industry. XMTR outperforms 89.80% of its industry peers.
XMTR has a Quick Ratio of 3.85. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of XMTR (3.85) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.85
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
The Revenue has grown by 20.19% in the past year. This is a very strong growth!
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%

3.2 Future

Based on estimates for the next years, XMTR will show a very strong growth in Earnings Per Share. The EPS will grow by 197.09% on average per year.
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 18.30% on average per year.
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue Next Year21.01%
Revenue Next 2Y19.4%
Revenue Next 3Y18.47%
Revenue Next 5Y18.3%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

XMTR is valuated quite expensively with a Price/Earnings ratio of 277.63.
73.47% of the companies in the same industry are cheaper than XMTR, based on the Price/Earnings ratio.
XMTR is valuated expensively when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 68.20, the valuation of XMTR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XMTR indicates a slightly more expensive valuation: XMTR is more expensive than 75.51% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.36. XMTR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 277.63
Fwd PE 68.2
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 197.09% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y317.97%
EPS Next 3Y197.09%

More info and screens

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (10/6/2025, 9:11:56 PM)

After market: 52.75 0 (0%)

52.75

+1.23 (+2.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners101.05%
Inst Owner Change0%
Ins Owners5.78%
Ins Owner Change-1.47%
Market Cap2.68B
Analysts81.25
Price Target47.69 (-9.59%)
Short Float %13.09%
Short Ratio6.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)319.09%
Min EPS beat(2)96.56%
Max EPS beat(2)541.62%
EPS beat(4)4
Avg EPS beat(4)230.87%
Min EPS beat(4)96.56%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)136.96%
EPS beat(12)11
Avg EPS beat(12)97.33%
EPS beat(16)14
Avg EPS beat(16)77.75%
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)0.52%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.79%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.8%
Revenue beat(16)9
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)35.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.27%
EPS NY rev (1m)2.99%
EPS NY rev (3m)20.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.88%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE 277.63
Fwd PE 68.2
P/S 4.44
P/FCF N/A
P/OCF 2010.27
P/B 9.91
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.19
EY0.36%
EPS(NY)0.77
Fwd EY1.47%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.03
OCFY0.05%
SpS11.89
BVpS5.32
TBVpS-0.47
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.15%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.13%
Cap/Sales 3.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.85
Altman-Z 4.01
F-Score5
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%
Revenue Next Year21.01%
Revenue Next 2Y19.4%
Revenue Next 3Y18.47%
Revenue Next 5Y18.3%
EBIT growth 1Y19.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.04%
EBIT Next 3Y64.61%
EBIT Next 5Y46.68%
FCF growth 1Y69.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.61%
OCF growth 3YN/A
OCF growth 5YN/A